ADMS - New CEO at Adamas Pharma September, 13 2019 07:40 AM Adamas Pharmaceuticals Inc. Adamas Pharmaceuticals (NASDAQ:ADMS) appoints Neil McFarlane as CEO and the member of Board of Directors, effective September 16, 2019.More news on: Adamas Pharmaceuticals, Inc., Healthcare stocks news, Read more ...